ReviewJournal of neurology2012
A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.
Review in Journal of neurology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- First case report on Bickerstaff brainstem encephalitis in a young adult from Syria: Bridging clinical knowledge and practice.Radiology case reports · 2025Article
- Acute disseminated encephalomyelitis in a young patient: A case report.Experimental and therapeutic medicine · 2024Article
- Long-term outcomes of ADEM-like and tumefactive presentations of CNS demyelination: a case-comparison analysis.Journal of neurology · 2024Article
- Magnetic Resonance Imaging of Autoimmune Demyelinating Diseases as a Diagnostic Challenge for Radiologists: Report of Two Cases and Literature Review.Life (Basel, Switzerland) · 2022Review
- Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases.Therapeutic advances in neurological disorders · 2021Article
- Biomarkers in Rare Demyelinating Disease of the Central Nervous System.International journal of molecular sciences · 2020Review
- Serum levels of cell adhesion molecules in patients with neuromyelitis optica spectrum disorder.Annals of clinical and translational neurology · 2020Article
- Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature.Frontiers in neurology · 2020Article
- Interleaved susceptibility-weighted and FLAIR MRI for imaging lesion-penetrating veins in multiple sclerosis.Magnetic resonance in medicine · 2018Article
- Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications.The British journal of radiology · 2017Review
- Lethal high: acute disseminated encephalomyelitis (ADEM) triggered by toxic effect of synthetic cannabinoidBMJ case reports · 2017Article
- Young Man With Headache, Confusion, and Hearing Loss.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2015Article
- Neuromyelitis optica spectrum disorders associated with other autoimmune diseases.Rheumatology international · 2015Review
- Differential diagnosis of white matter lesions: Nonvascular causes-Part II.Clinical neuroradiology · 2014Review
- Frequency of autoantibodies and connective tissue diseases in Chinese patients with optic neuritis.PloS one · 2014Article
- Variants in the promoter region of CYP7A1 are associated with neuromyelitis optica but not with multiple sclerosis in the Han Chinese population.Neuroscience bulletin · 2013Article
- Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.Journal of neurology · 2013Article
- Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system.Journal of neurology · 2013Review
- Multiple sclerosis imaging: recent advances.Journal of neurology · 2013Review
- Transverse myelitis.Neurologic clinics · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although multiple sclerosis (MS) is the most common demyelinating disorder of the central nervous system (CNS), it lacks any definitive diagnostic test. Instead, diagnosis of MS primarily depends upon clinical criteria, supported by abnormalities characteristic of MS on para-clinical investigations including magnetic resonance imaging of the brain and spine, in the absence of an alternative explanation for underlying neurologic symptoms. While many of the potential disorders that may mimic MS in routine clinical practice are either extremely rare, or associated with specific and characteristic distinguishing diagnostic features, some inflammatory demyelinating disorders of the CNS may be particularly challenging to distinguish from MS, especially during initial presentation. In particular, acute disseminated encephalomyelitis, neuromyelitis optica, and idiopathic transverse myelitis may closely resemble MS, impeding prompt and accurate diagnosis. In this review, we describe the clinical features, diagnosis, pathology, and treatment of these other CNS demyelinating disorders. In addition, we review relevant features of other CNS inflammatory disorders that may mimic MS, including Sjögren's syndrome, systemic lupus erythematosus, Behçet's disease, and primary CNS vasculitis.
Indexed as
Identifiers
21932127What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.